Interrater reliability of the nih stroke scale

Archives of Neurology

Volumn 46, Issue 6, 1989, Pages 660-662

  Goldstein, Larry B ^a   Bertels, Christina ^a   Davis, James N ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; METHODOLOGY; PRIORITY JOURNAL;

CEREBROVASCULAR DISORDERS; HUMAN; NATIONAL INSTITUTES OF HEALTH (U.S.); SEVERITY OF ILLNESS INDEX; STATISTICS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 0024321863     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1989.00520420080026     Document Type: Article

References (20)

1. 1. Asplund K. Clinimetrics in stroke research. Stroke. 1987;18:528-530.
2. 2. Biller J, Massey EW, Adams HP, et al. A dose escalation study of ORG10172 in the treatment of acute cerebral infarction. Ann Neurol. 1987;22:159.
3. 3. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia, Pa: Lea & Febiger; 1972.
4. 4. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
5. 5. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons Inc; 1981;229-232.
6. 6. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76:378-382.
7. 7. Fleiss JL, Nee JCM, Landis JR. Large sample variance of kappa in the case of different sets of raters. Psychol Bull. 1979;86:974-977.
8. 8. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
9. 9. Kramer MS, Feinstein AR. Clinical biostatistics, LIV: the biostatistics of concordance. Clin Pharmacol Ther. 1981;29:111-123.
10. 10. Mathew NT, Meyer JS, Rivera VM, Charney JZ, Hartmann A. Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet. 1972;2:1327-1329.
11. 11. Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJA. Assessment of interobserver variability in a Dutch multicenter study on acute ischemic stroke. Stroke. 1988;19:709-711.
12. 12. Cote R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke. 1986;17:731-737.
13. 13. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-220.
14. 14. Shinar D, Gross CR, Mohr JP, et al. Inter-observer variability in the assessment of neurologic history and examination in the Stroke Data Bank.American Medical Association. 1985;42:557-565.
15. 15. Spence JD, Donner A. Problems in design of stroke treatment trials. Stroke. 1982;13:94-99.
16. 16. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient, I: A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13-31.
17. 17. Duncan PW, Propst M, Nelson SG. Reliability of Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. J Am Phys Ther Assoc. 1983;63:1606-1610.
18. 18. Poole JL, Whitney SL. Motor Assessment Scale for Stroke Patients: concurrent validity and interrater reliability. Arch Phys Med Rehabil. 1988;69:195-197.
19. 19. Feigenson JS. Toward a uniform assessment of 'outcome.' Stroke. 1982;13:873-876.
20. 20. Adams HP, Olinger CP, Barsan WG. A dose-escalation study of large doses of naloxone for the treatment of patients with acute cerebral ischemia. Stroke. 1986;17:404-409.